Newsletter

Fibrodysplasia Ossificans Progressiva
With no cure at hand Pharma companies gear up to offer relief to patients suffering from a sporadic connective tissue disease.
Fibrodysplasia Ossificans Progressiva Newsletter

More Whitepapers / Newsletters

Impact of Brexit on Pharma Space Newsletter
Impact Of BREXIT On Pharma Spa...

The Union of the European countries, also known as the European Union or the EU, is more or less like a conglomerate of countries. These countries make up the whole continent. The economic and politic...

Prader-Willi Syndrome
Prader-Willi Syndrome

A complex genetic condition, Prader-Willi syndrome (PWS) is a result of the loss of the functioning of genes in a particular region of chromosome 15. Genetic testing confirms the definitive diagnosis...

Automated Insulin Delivery Market
Automated Insulin Delivery

Advances in continuous glucose monitoring (CGM) has led to a paradigm shift in the management of type 1 diabetes. The developments have enabled the automation of insulin delivery, where an algorithm d...

Gaucher Disease Newsletter
Gaucher Disease

The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required for the break-down of glucocerebroside thus causing a build-up in ar...

Schizophrenia Market
Schizophrenia

Schizophrenia is a severe mental illness that interferes with a person's ability to think clearly, manage emotions, make decisions, and relate to others. It is a complex, long-term medical illness, af...